Date | Insider | Price | Amount |
---|---|---|---|
2-17-2021 Insider Buy |
James E. Flynn Director and >10% Owner |
$19.00 CAGR » |
$5,700,000.00 300,000 shares |
10-6-2020 Insider Buy |
Oncology Impact Fund L.P. Ubs >10% Owner |
$15.00 CAGR » |
$2,268,360.00 151,224 shares |
10-6-2020 Insider Buy |
Luke Evnin Director and >10% Owner |
$15.00 CAGR » |
$2,268,375.00 151,225 shares |
10-6-2020 Insider Buy |
Ansbert Gadicke >10% Owner |
$15.00 CAGR » |
$4,875,000.00 325,000 shares |
10-6-2020 Insider Buy |
MPM BioVentures 2014, L.P. >10% Owner |
$15.00 CAGR » |
$2,606,640.00 173,776 shares |
10-6-2020 Insider Buy |
MPM SunStates Fund, L.P. >10% Owner |
$15.00 CAGR » |
$2,606,640.00 173,776 shares |
10-6-2020 Insider Buy |
James E. Flynn Director and >10% Owner |
$15.00 CAGR » |
$15,000,000.00 1,000,000 shares |
Also See: Institutional Holders of ONCR
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 02/18/2021 | |
End date: | 06/29/2023 | |
Start price/share: | $16.19 | |
End price/share: | $0.04 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.78% | |
Average Annual Total Return: | -92.52% | |
Starting investment: | $10,000.00 | |
Ending investment: | $22.22 | |
Years: | 2.36 |
ONCR Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ONCR insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ONCR
Free ONCR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the ONCR Insider Buying occurred are:
SNGX Insider Buying |